[Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor
Affiliations: Department of Pediatric Gastroenterology, The First Hospital, jilin University, Changchun, jilin 130021, P.R. China, The Experiment Center, College of Basic Medical Sciences, jilin University, Changchun, jilin 130021, P.R. China, Department of Hepatology, The First Hospital, jilin University, Changchun, jilin 130021, P.R. China
- Published online on: June 14, 2021 https://doi.org/10.3892/or.2021.8113
- Article Number: 161
Copyright : © Pang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Rep 34: [Related article:] 3272-3279, 2015; DOI: 10.3892/or.2015.4321
Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that certain of the western blotting data shown in Fig. 3C, 4D, 5A and 6D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.